http://www.youtube.com/watch?v=wBhZoTN2bvM
Life might be like a box of chocolates, but for the actor who made the line famous in Forrest Gump, he’ll probably have to do without them. This week, Academy Award winner Tom Hanks joined the rapidly increasing Type 2 diabetes population. He talked about it during an interview on Late Night with David Letterman where he recounted how his doctor broke the news.
“You know those high blood-sugar numbers you’ve been dealing with since you were 36? Well, you’ve graduated! You’ve got Type 2 diabetes, young man.'”
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
Hanks is now one of the more than 25.8 million people diagnosed with the condition. Of those, about 7 million are undiagnosed, according to 2011 data from the American Diabetes Association.
I wonder which organizations or companies will approach the actor to get a celebrity endorsement. Last year Danish drugmaker Novo Nordisk partnered with Food Network chef Paula Deen last year. Deen and Novo Nordisk launched a website to raise awareness of the condition. She also shares low-fat versions of her the high-calorie dishes that she produced on her cooking show on the Food Network. Paul Sorvino, with his daughter Mira is a celebrity spokesman for Sanofi. Dick Clark was a spokesman for the American Diabetes Association for years.
Hanks’ diagnosis comes at a time when researchers and startups are laser focused on helping people better manage the condition or prevent if possible. Some are developing analytics tools from big data to do a better job of predicting who has the chronic condition even before they are diagnosed.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
